XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Other Intangibles
3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangibles

Note 5 – Goodwill and Other Intangibles

Goodwill

Changes in the carrying amount of goodwill, by reportable segment, for the three months ended March 31, 2023 was as follows:

 

 

Automotive

 

 

Medical

 

 

Total

 

Balance as of December 31, 2022

 

$

73,069

 

 

$

46,705

 

 

$

119,774

 

Currency translation

 

 

949

 

 

 

232

 

 

 

1,181

 

Balance as of March 31, 2023

 

$

74,018

 

 

$

46,937

 

 

$

120,955

 

Other Intangible Assets

Other intangible assets and accumulated amortization balances as of March 31, 2023 and December 31, 2022 were as follows:

 

 

March 31, 2023

 

 

December 31, 2022

 

 

 

Gross
Carrying Value

 

 

Accumulated
Amortization

 

 

Net Carrying
Value

 

 

Gross
Carrying Value

 

 

Accumulated
Amortization

 

 

Net Carrying
Value

 

Definite-lived:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Customer relationships

 

$

113,909

 

 

$

(68,795

)

 

$

45,114

 

 

$

112,286

 

 

$

(65,748

)

 

$

46,538

 

Technology

 

 

45,340

 

 

 

(26,696

)

 

 

18,644

 

 

 

44,745

 

 

 

(25,709

)

 

 

19,036

 

Product development costs

 

 

19,051

 

 

 

(18,884

)

 

 

167

 

 

 

18,774

 

 

 

(18,456

)

 

 

318

 

Software development

 

 

1,007

 

 

 

 

 

 

1,007

 

 

 

1,007

 

 

 

 

 

 

1,007

 

Indefinite-lived:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tradenames

 

 

7,119

 

 

 

 

 

 

7,119

 

 

 

7,034

 

 

 

 

 

 

7,034

 

Total

 

$

186,426

 

 

$

(114,375

)

 

$

72,051

 

 

$

183,846

 

 

$

(109,913

)

 

$

73,933

 

In addition to annual impairment testing, which is performed in the fourth quarter of each fiscal year, the Company continuously monitors for events and circumstances that could negatively impact the key assumptions used in determining fair value and therefore require interim impairment testing, including long-term revenue growth projections, profitability, discount rates, recent market valuations from transactions by comparable companies, volatility in the Company's market capitalization, and general industry, market and macroeconomic conditions. We are not presently aware of any events or circumstances that would require us to revise the carrying value of our assets or liabilities as of March 31, 2023.